Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Clinical trial NCT00433017 · TERMINATED
Trial details
- NCT number
- NCT00433017
- Sponsor
- Novartis
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-07-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.